On August 22, BlackRock Inc (NYSE: BLK) unveiled three new fixed income exchange traded funds, offering investors a BuyWrite strategy on fixed income assets.
Cathie Wood-led Ark Investment Management bought 129,800 shares of healthcare company Teladoc Health Inc (NYSE: TDOC), valued at over $4.5 million, based on Tuesday’s closing price, via four of its exchange-traded funds (ETFs).
A leader in leveraged and inverse and thematic ETFs is launching new investment options for investors looking to place bets for or against two of the largest and most well-known companies in the world. Here are the details.
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.
One of the favorite stocks of Cathie Wood and Ark Funds is Roku Inc (NASDAQ: ROKU). Here’s what Wood had to say this weekend about the streaming hardware and platform company.
Virtual healthcare provider Teladoc Health (NYSE: TDOC) has been a favorite stock pick of Cathie Wood, CEO of Ark Invest. After shares dropped 18% on Thursday from second quarter financial results, Wood defended the pick and bought the dip.
Ark Funds CEO Cathie Wood has been known to make some highly criticized forward-looking predictions. Wood and her colleagues have some of the higher price targets on Wall Street for Bitcoin (CRYPTO: BTC).
New ETFs that offer investors the opportunity to be bullish or bearish on individual stocks hit the market this week. The new leveraged and inverse daily ETFs could be the first of many and could take on some of the largest companies in the world.
Oil has been in a freefall. The ProShares UltraShort Bloomberg Crude Oil ETF (NYSE: SCO) has been skyrocketing. And if oil keeps dropping, SCO will move even higher.